VIR-7831

sotrovimab · Vir Biotechnology

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for VIR-7831, covering 2021-04-15 to 2023-11-18. Get the full timeline:

Most recent: Clinical Trial Update: VIR-7831 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial) [Phase 3]